The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 4, 1997, Pages 330-334

  Van Tellingen, Olaf ^a   Boogerd, Willem ^a   Nooijen, Willem J ^a   Beijnen, Jos H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Brain; Malignant glioma; Metastasis; Teniposide

Indexed keywords

ALBUMIN; TENIPOSIDE;

ADULT; AGED; ARTICLE; AUTOPSY; BLOOD; BRAIN METASTASIS; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; GLIOBLASTOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; TECHNIQUE; TISSUE DISTRIBUTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN; BRAIN NEOPLASMS; BREAST NEOPLASMS; CAPILLARY PERMEABILITY; CEREBROVASCULAR CIRCULATION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MELANOMA; MIDDLE AGED; OLIGODENDROGLIOMA; SKIN NEOPLASMS; TENIPOSIDE;

EID: 0030958676     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050665     Document Type: Article

References (16)

1. Allen LM, Creaven PJ (1975) Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotixin glucopyranoside derivatives. Eur J Cancer 11: 697-707
2. Cairncross G, MacDonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C (1994) Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12: 2013-2021
3. DeAngelis LM, Yahaloma J, Thaler HT, Kher U (1992) Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635-643
4. D'Incalci M, Rossi C, Sessa C, Urso R, Zucchetti M, Farina P, Mangioni C (1985) Pharmacokinetics of teniposide in patients with ovarian cancer. Cancer Treat Rep 69: 73-77
5. Greig NH (1989) Brain tumors and the blood-tumor barrier. In: Neuwelt EA (ed) Implications of the blood-brain barrier and its manipulation, vol 2. Plenum, New York, pp 77-106
6. Holthuis JJM, Romkens FMGM, Pinedo HM, Van Oort WJ (1983) Plasma assay for the antineoplastic agent VP16-213 (etoposide) using high-performance liquid chromatography with electrochemical detection. J Pharm Biomed Anal 1: 89-97
7. Kristensen CA, Kristjansen PE, Hansen HH (1992) Systemic chemotherapy of brain metastases from small-cell lung cancer: a review. J Clin Oncol 10: 1498-1502
8. Petros WP, Rodman JH, Relling MV, Christensen M, Pui CH, Rivera GK, Evans WE (1992) Variability in teniposide plasma protein binding is correlated with serum albumin concentrations. Pharmacotherapy 12: 273-277
9. Plate KH, Mennel HD (1995) Vascular morphology and angiogenesis in glial tumors. Exp Toxicol Pathol 47: 89-94
10. Proost JH, Meijer DKF (1992) MW/PHARM, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput Biol Med 22: 155-160
11. Roed H, Vindelov LL, Christensen IJ, Spang-Thomsen M, Hansen HH (1987) The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung. Cancer Chemother Pharmacol 19: 16-20
12. Schinkel AH, Smit JJ, Van Tellingen O, Beijnen JH. Wagenaar E, van Deemter L, Mol CA. van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM, Borst P (1994) Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491-502
13. Stewart DJ, Richard MT, Hugenholtz H, Dennery J, Nundy D, Prior J, Montpetit V, Hopkins HS (1984) Penetration of teniposide (VM-26) into human intracerebral tumors, preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin b or oral glycerol. J Neurooncol 2: 315-324
14. Vaupel P (1994) Blood flow and metabolic microenvironment of brain tumors. J Neurooncol 22: 261-267
15. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK (1994) Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 54: 4564-4568
16. Zucchetti M, Rossi C, Knerich R, Donelli MG, Butti G, Silvani V, Gaetani P, D'Incalci M (1991) Concentrations of VP16 and VM26 in human brain tumors. Ann Oncol 2: 63-66